Massachusetts Financial Services’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-26,749
Closed -$577K 949
2021
Q3
$577K Sell
26,749
-351
-1% -$8.47K ﹤0.01% 866
2021
Q2
$695K Buy
27,100
+233
+0.9% +$4.98K ﹤0.01% 865
2021
Q1
$490K Sell
26,867
-3,186
-11% -$52.9K ﹤0.01% 883
2020
Q4
$347K Sell
30,053
-301
-1% -$2.75K ﹤0.01% 854
2020
Q3
$231K Buy
+30,354
New +$230K ﹤0.01% 858

Other funds holding CDMO

Massachusetts Financial Services's CDMO Position: Q4 2021 in Review

Massachusetts Financial Services sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2021, closing a stake of 26,749 shares — an estimated $577K sold.

Massachusetts Financial Services first reported a position in CDMO in Q3 2020 and held it in 5 quarters. The position peaked at $695K in Q2 2021. 190 funds tracked by Wall St. Rank hold CDMO as of Q4 2021.

  • Massachusetts Financial Services reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 26,749 Avid Bioservices, Inc. Common Stock shares in Q4 2021, an estimated $577K.
  • Massachusetts Financial Services first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Massachusetts Financial Services's Avid Bioservices, Inc. Common Stock position peaked at $695K in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2021.

Based on Massachusetts Financial Services's 13F filing for Q4 2021, filed 10 Feb 2022.